Montelukast Sodium Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2022 - 2027

Report Code: HCR 35774 Report Format: PDF + Excel

Montelukast Sodium Market Overview

Montelukast Sodium Market size is estimated to reach $946 million by 2027, growing at a CAGR of 11.3% during the forecast period 2022-2027. Montelukast Sodium which is widely retailed under the term Singulair which is demarcated as a leukotriene inhibitor accustomed to treat complications such as shortness of breath ascribed to Asthma. Besides Asthma treatment, it is also used to cure several allergic and fungal infections as a pre-workout before doing exercises to avert compilations related to breathing. Montelukast Oral Granules tablets are commonly prescribed by doctors to cure allergic or fungal contagions. Consumption of such drugs is elevating as respiratory maladies such as Pneumonia, lung hitches, COPD, Asthma, and Emphysema are broadening due to shooting up pollution, stimulating smoking trends among teenagers. Proliferating contagions as the old-age population is soaring in developing as well as developed countries post COVID-19 are set to drive the growth of the Montelukast Sodium Industry for the period 2022-2027.

Report Coverage:

The report: “Montelukast Sodium Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Montelukast Sodium Market.

By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, and many more.
By Dose Type: Simple Pills, chewable Pills, Powder, Liquid Solutions.
By Product: Crystal-like and Form-less/Amorphous.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways:

  • Geographically, the North America Montelukast Sodium Market accounted for the highest revenue share in 2021. However, Asia-pacific is poised to dominate the market over the period 2022-2027 owing to the intensification in the old-age population.
  • The heightening pollution which is soaring the respiratory complication is driving the Montelukast Sodium Market. However, many side-effects associated with inhibitor consumption is one of the major factors that are said to reduce the growth of the Montelukast Sodium Market.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Montelukast Sodium Market report.

    Montelukast Sodium Market- Geography (%) for 2021

    Montelukast Sodium Market

For More Details on This Report - Request for Sample

Montelukast Sodium Market Segment Analysis - By Application

The Montelukast Sodium Market based on the Application can be further segmented into Bronchospasm, Allergic Coryza, Asthma, Urticaria, and many more. The Allergic Coryza segment held the largest share owing to the factors such as pollen a powder produced by several trees, grasses, and flowers which leads to allergic- rhinitis. Growing emissions of carbon dioxide ultimately pollute the environment and eventually elongate pollen periods. The elongated pollens period stimulates the pace of occurrence of maladies such as headaches, dark circles, watery eyes and nose, coughing, and throat pain.

Moreover, the Asthma segment is estimated to be the fastest-growing segment with a CAGR of 11.9% over the period 2022-2027. This growth is owing to swelling Bronchospasm hitches in many young and adult people, augmenting respiratory maladies due to soaring allergens in the air due to environmental pollution, accruing old-age population which is more prone to hazard effects of allergen or pollutants. Additionally, environmental factors such as a high AQI will further propel their demand. For example, in countries like India, the AQI for 20 out of 30 states has recorded an AQI >101, thereby marking it poor, and further making the cases of Asthma grow.

Montelukast Sodium Market Segment Analysis - By Dose Type

The Montelukast Sodium Market based on the Dose Type can be further segmented into Simple Pills, chewable Pills, Powder, Liquid Solutions. The Simple Pill segment held the largest share in 2021 owing to the factors such as lower cost of manufacturing as compared to other forms, preferred by maximum people due to several features over liquid and powder form such as no unpleasant smell as the drugs is extremely compact and coated with sugar or enteric.

Similarly, the Pills/Tablets segment is estimated to be the fastest growing with a CAGR of 12.0% over the forecast period 2022-2027. This growth is owing to broadening demand for the geriatric population as it is the most common form consumed, high accuracy of pills as drugs are protected from environmental conditions such as air and moisture due to proper coating, the possibility of bulk production, and low production cost for companies.

Montelukast Sodium Market Segment Analysis - By Geography

The Montelukast Sodium Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 33% of the overall market in 2021. The growth in this segment is owing to the factors such as proliferating cases of breathing abnormalities due to the increasing trend of smoking among teenagers and the adult population, poor ingestion habits leading to complications like obesity. On other hand, well-established healthcare infrastructure as the widescale presence of various retail pharmacies and drug stores are driving the overall consumption of the drug. Approximately, 25 million Americans have had asthma, which roughly translates to 1 in every 13.

However, the Asia-Pacific segment is estimated to be the fastest-growing over the forecast period 2022-2027. This growth is owing to expanding old-age population especially in countries like India and China, soaring pollution problem as both the countries are biggest carbon emitter worsening the problems like asthma. On another hand as the GDPs of these nations are prospering, they can afford to fuel more money into research and development.

Montelukast Sodium Market Drivers

Growing geriatric population Projected to Drive Market Growth

The world population is growing at a steady pace especially in Asian nations like India and China as both nations contribute around 36% to the total world population. Out of 7.9 billion people, around 4.6 billion people live in Asia. Along with the overall shoot up in population old-age faction is also elevating. There are around 700 million people aged above 65 and the number is expected to enlarge up to 1-2 billion in the coming future. Old age carries corporeal misery and is more prone to respiratory problems.

The soaring pollution problem is Expected to Boost Product Demand

The pollution problem is accruing around the globe due to rapid industrialization. Overuse of coal to produce electricity and several production processes is increasing the carbon content in the environment and resulting in rising temperature. On other hand, due to rising disposable income people’s purchasing power is on the rise. As a result, they are making automobile purchases. All these factors increase the pollution, which is resulting in health complications like asthma, allergic coryza. As per WHO, an air quality above >101 can result in asthma and other bronchial problems in susceptible patients. Following this, countries such as India and China have been a forefront leader in terms of high AQI, which will allow for market growth.

Montelukast Sodium Market Challenges

Side effects associated with usage of Montelukast inhibitor are Anticipated to Hamper Market Growth

Montelukast Sodium may be quite beneficial in treating breathing complications, Asthma, and many allergies but one factor that can strangle the steady progress of the Montelukast Sodium Market is several health side-effects associated with its use as a leukotriene inhibitor. Some adverse effects are drowsiness, gastrointestinal discomfort, nausea, diarrhea, looseness, respiratory dysfunction such as congestion, cough, and sore throat. These problems may turn patients aversive toward consumption of montelukast and can cripple its overall market.

Montelukast Sodium Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in this market. Montelukast Sodium top 10 Companies

  1. Cipla
  2. Merck & Co.
  3. Hetero Labs
  4. Ortin laboratories
  5. Mylan N.V
  6. Morepen laboratories
  7. Teva Pharmaceuticals
  8. MSN Laboratories
  9. Vamsi Labs
  10. Medopharm

Recent Developments

  • In May 2021, Montelukast Sodium was included in the Health Choice Arizona Formulary / Preferred Drug List. A Formulary / Preferred Drug List (PDL) is a list of drugs chosen by Health Choice Arizona and a team of doctors and pharmacists. Health Choice will cover the drugs listed in our PDL as long as they are medically necessary and appropriate. All Health Choice member prescriptions must be filled at a Health Choice Arizona network pharmacy, and other plan rules must be followed.
  • March 4, 2020, US FDA requires the drug manufacturers to put up a strong warning about the risk of developing Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast. The incidence of neuropsychiatric events associated with montelukast is unknown, but some reports are serious, and many patients and health care professionals are not fully aware of these risks. The FDA determined the risks of montelukast may outweigh the benefits in some patients, particularly when the symptoms of the disease are mild and can be adequately treated with alternative therapies.

Relevant Links:

Report Code: HCR 84738

Report Code: HCR 32171

For more Lifesciences and Healthcare Market reports, please click here

1. Montelukast Sodium Market Overview
    1.1 Definitions and Scope
2. Montelukast Sodium Market - Executive Summary
3. Montelukast Sodium Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Montelukast Sodium Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Montelukast Sodium Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Montelukast Sodium Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Montelukast Sodium Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Montelukast Sodium Market - By Application (Market Size –$Million/$Billion) 
    8.1 Bronchospasm
    8.2 Allergic Coryza
    8.3 Asthma
    8.4 Urticaria
9. Montelukast Sodium Market – By Dose Type (Market Size –$Million/$Billion) 
    9.1 Simple Pills
    9.2 Chewable Pills
    9.3 Powder
    9.4 Liquid Solutions
10. Montelukast Sodium Market – Product (Market Size –$Million/$Billion) 
    10.1 Crystal-like
    10.2 Form-less/Amorphous
11. Montelukast Sodium Market- By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific 
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of World
        11.5.1 Middle East
        11.5.2 Africa
12. Montelukast Sodium Market- Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs, and partnerships
13. Montelukast Sodium Market– Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Montelukast Sodium Market– Key Company List by Country Premium (Premium)
15. Montelukast Sodium Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies" 

LIST OF TABLES

1.Global Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
1.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Global Industry Research
1.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Global Industry Research
2.Global Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
2.1 Tablet Market 2019-2024 ($M) - Global Industry Research
2.2 Chewable Tablet Market 2019-2024 ($M) - Global Industry Research
2.3 Oral Solution Market 2019-2024 ($M) - Global Industry Research
3.Global Montelukast Sodium Market, By Product Type Market 2019-2024 (Volume/Units)
3.1 Montelukast Sodium Amorphous Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Montelukast Sodium Crystalline Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Montelukast Sodium Market, By Dosage Form Market 2019-2024 (Volume/Units)
4.1 Tablet Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Chewable Tablet Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Oral Solution Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
5.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
5.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
6.North America Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
6.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
6.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
6.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
7.South America Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
7.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
7.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
8.South America Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
8.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
8.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
8.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
9.Europe Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
9.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
9.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
10.Europe Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
10.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
10.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
10.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
11.APAC Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
11.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
11.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
12.APAC Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
12.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
12.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
12.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research
13.MENA Montelukast Sodium Market, By Product Type Market 2019-2024 ($M)
13.1 Montelukast Sodium Amorphous Market 2019-2024 ($M) - Regional Industry Research
13.2 Montelukast Sodium Crystalline Market 2019-2024 ($M) - Regional Industry Research
14.MENA Montelukast Sodium Market, By Dosage Form Market 2019-2024 ($M)
14.1 Tablet Market 2019-2024 ($M) - Regional Industry Research
14.2 Chewable Tablet Market 2019-2024 ($M) - Regional Industry Research
14.3 Oral Solution Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Montelukast Sodium Market Revenue, 2019-2024 ($M)
2.Canada Montelukast Sodium Market Revenue, 2019-2024 ($M)
3.Mexico Montelukast Sodium Market Revenue, 2019-2024 ($M)
4.Brazil Montelukast Sodium Market Revenue, 2019-2024 ($M)
5.Argentina Montelukast Sodium Market Revenue, 2019-2024 ($M)
6.Peru Montelukast Sodium Market Revenue, 2019-2024 ($M)
7.Colombia Montelukast Sodium Market Revenue, 2019-2024 ($M)
8.Chile Montelukast Sodium Market Revenue, 2019-2024 ($M)
9.Rest of South America Montelukast Sodium Market Revenue, 2019-2024 ($M)
10.UK Montelukast Sodium Market Revenue, 2019-2024 ($M)
11.Germany Montelukast Sodium Market Revenue, 2019-2024 ($M)
12.France Montelukast Sodium Market Revenue, 2019-2024 ($M)
13.Italy Montelukast Sodium Market Revenue, 2019-2024 ($M)
14.Spain Montelukast Sodium Market Revenue, 2019-2024 ($M)
15.Rest of Europe Montelukast Sodium Market Revenue, 2019-2024 ($M)
16.China Montelukast Sodium Market Revenue, 2019-2024 ($M)
17.India Montelukast Sodium Market Revenue, 2019-2024 ($M)
18.Japan Montelukast Sodium Market Revenue, 2019-2024 ($M)
19.South Korea Montelukast Sodium Market Revenue, 2019-2024 ($M)
20.South Africa Montelukast Sodium Market Revenue, 2019-2024 ($M)
21.North America Montelukast Sodium By Application
22.South America Montelukast Sodium By Application
23.Europe Montelukast Sodium By Application
24.APAC Montelukast Sodium By Application
25.MENA Montelukast Sodium By Application
26.Merck Sharp Dohme Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Morepen Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Mylan N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Roxane Laboratories, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glenmark Generic Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Sandoz International Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Vintage Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Kudco Ireland Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Apotex Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)